Terpenoid ID | TKC019571 | |
Cell line | 0 | |
Protein target | 12 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 57 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC019571 | Lymphoblastoid cells | 7943.0 | nM | Potency | |||
TKC019571 | SN12C | SN-12C | 7079.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC019571 | NCI-H23 | NCI.H23; NCI H23; H-23; H23; NCIH23 | 16943.0 | nM | GI50 | C3512 | |
TKC019571 | ACHN | 100000.0 | nM | GI50 | C6975 | Orphanet_319298 | |
TKC019571 | UO-31 | UO.31; UO31; U031 | 27733.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC019571 | HOP-92 | HOP 92; HOP.92; HOP92; Hop92; Hopkins-92 | 24266.0 | nM | GI50 | C2926 | |
TKC019571 | HL-60 | HL 60; HL.60 HL60; Human Leukemia-60 | 17061.0 | nM | GI50 | C9154 | Orphanet_519 |
TKC019571 | SF-539 | SF-539; SF-539 BT; SF.539; SF 539 | 18323.0 | nM | GI50 | C3796 | Orphanet_251576 |
TKC019571 | SK-MEL-5 | SK-Mel-5; SK MEL 5; SK.MEL.5; SK-MEL5; SKMel-5; SKMEL-5; SKMEL5; SKMel5; SKmel5; AA-Mel | 5495.0 | nM | GI50 | C3510 | |
TKC019571 | Malme-3M | MALME-3M; MALME 3M; Malme-3 M; MALME.3M; Malme3M; MALME3M; Malme-3 Monolayer | 54576.0 | nM | GI50 | C3224 | |
TKC019571 | A498 | A498 | 923.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC019571 | K562 | K562; K.562; K 562; KO; GM05372; GM05372E | 44361.0 | nM | GI50 | C9110 | Orphanet_521 |
TKC019571 | OVCAR-3 | Ovcar-3; OVCAR 3; OVCAR.3; NIH:OVCAR-3; NIH:Ovcar-3; NIH:OVCAR3; NIH-OVCAR-3; NIHOVCAR3; OVCAR3; Ovcar3 | 36058.0 | nM | GI50 | C105555 | |
TKC019571 | MOLT-4 | Molt-4; MOLT 4; Molt 4; MOLT.4; MOLT4; Molt4; GM02219; GM02219C; GM2219C; GM02219D | 13677.0 | nM | GI50 | C9142 | Orphanet_99861 |
TKC019571 | NCI/ADR-RES | NCI/ADR-RES; NCI.ADR.RES; NCIADR.RES; NCI/ADRRES; NCIADRRES; ADR-RES; MCF-7/ADR; MCF-7/ADR-RES; MCF-7/AdrR; MCF-7/Adr; MCF-7/adr; MCF-7ADR; MCF7-ADR; MCF7ADR; OVCAR-8/ADR; OVCAR8/ADR | 45186.0 | nM | GI50 | C105555 | |
TKC019571 | HOP-62 | HOP 62; Hop 62; HOP.62; HOP62; Hop62; Hopkins-62 | 12560.0 | nM | GI50 | C3512 | |
TKC019571 | U-251 | U-251 MG; U-251-MG; U-251_MG; U251-MG; U251MG; U-251; U251; U251n; U251N; 251 MG; 251MG; 251 MG(6) | 29512.0 | nM | GI50 | C60781 | Orphanet_94 |
TKC019571 | OVCAR-8 | OVCAR 8; NIH:OVCAR-8; OVCAR8; Ovcar8; OVCAR.8; OVCA8 | 24434.0 | nM | GI50 | C105555 | |
TKC019571 | OVCAR-5 | OVCAR 5; NIH:OVCAR-5; OVCAR.5; OVCAR5; Ovcar5; OVCA5 | 64714.0 | nM | GI50 | C105555 | |
TKC019571 | DMS-273 | DMS-273; DMS273; Darmouth Medical School 273 | 3565.0 | nM | GI50 | C4917 | Orphanet_70573 |
TKC019571 | SNB-19 | SNB.19; SNB19; Surgical Neurology Branch-19 | 28054.0 | nM | GI50 | C60781 | Orphanet_94 |
TKC019571 | TK-10 | TK.10; TK 10; TK10 | 100000.0 | nM | GI50 | C4033 | Orphanet_319276 |
TKC019571 | SR | SR-786; SR786 | 100000.0 | nM | GI50 | C37193 | Orphanet_300895 |
TKC019571 | M19-MEL | M-19; M19 | 11482.0 | nM | GI50 | C3802 | |
TKC019571 | SW-620 | SW-620; SW 620; SW.620 | 12134.0 | nM | GI50 | C4349 | |
TKC019571 | KM12 | KM-12; KM.12 | 33884.0 | nM | GI50 | C4910 | |
TKC019571 | NCI-H522 | NCI.H522; H522; H-522; NCI-522; NCI522; NCIH522 | 10069.0 | nM | GI50 | C3512 | |
TKC019571 | XF498 | XF-498; XF498 | 2163.0 | nM | GI50 | C3058 | Orphanet_360 |
TKC019571 | M14 | M14-MEL; UCLA-SO-M14; UCLA SO M14; UCLA-SO-14; UCLASO-M14; Melanoma 14; M-14 | 100000.0 | nM | GI50 | C3802 | |
TKC019571 | NCI-H322M | NCI.H322M; H322M; H-322M; H-322m | 28119.0 | nM | GI50 | C2923 | |
TKC019571 | RPMI-8226 | RPMI 8226; RPMI.8226; RPMI8226; RPMI no. 8226; RPMI no 8226; RPMI #8226; 8226; RPMI 8226/S; RPMI-8226S; RPMI8226/S; 8226/S; Roswell Park Memorial Institute 8226; GM02132; GM2132; GM 2132; GM02132C; Simpson | 23388.0 | nM | GI50 | C3242 | Orphanet_29073 |
TKC019571 | LOX IMVI | LOX/IMVI; LOX IMVI; LOXIM-VI; LOXIMVI; LOX | 7430.0 | nM | GI50 | C3802 | |
TKC019571 | OVCAR-4 | OVCAR 4; NIH:OVCAR-4; NIH:OVCAR4; OVCAR.4; OVCAR4; Ovcar4 | 61094.0 | nM | GI50 | C105555 | |
TKC019571 | P388 | P-388 | 9099.0 | nM | GI50 | C21602 | |
TKC019571 | KM-20L2 | KM-20L2; KM 20L2; KM 2012 | 38815.0 | nM | GI50 | C4349 | |
TKC019571 | SK-MEL-2 | SK-Mel-2; SK-Mel 2; SK-mel-2; SK-MEL2; SK.MEL.2; SK Mel 2; SK MEL 2; SKMEL-2; SKMEL2; SKmel2; SK-ML2; SKml2 | 47315.0 | nM | GI50 | C3224 | |
TKC019571 | A549 | 7889.0 | nM | GI50 | C3512 | ||
TKC019571 | HCC 2998 | HCC-2998; HCC.2998; HCC 2998; Hamon Cancer Center 2998 | 26363.0 | nM | GI50 | C4349 | |
TKC019571 | SNB-75 | SNB.75; SNB75; Surgical Neurology Branch-75 | 39264.0 | nM | GI50 | C3058 | Orphanet_360 |
TKC019571 | HCT-15 | HCT-15; HCT.15; HCT15 | 12078.0 | nM | GI50 | C4349 | |
TKC019571 | HCT-116 | HCT-116; HCT.116; HCT_116; HCT116; HCT116wt; CoCL2 | 14521.0 | nM | GI50 | C4910 | |
TKC019571 | SF-268 | SF-268; SF.268; SF 268 | 41976.0 | nM | GI50 | C60781 | Orphanet_94 |
TKC019571 | EKVX | 38019.0 | nM | GI50 | C3512 | ||
TKC019571 | MCF7 | 644.0 | nM | GI50 | C4194 | ||
TKC019571 | SK-OV-3 | SKOV-3; SK-OV3; SK.OV.3; SKOV3; Skov3; SKO3 | 57544.0 | nM | GI50 | C7978 | |
TKC019571 | LXFL 529 | LXFL-529L; LXFL529L; LXF 529 L; LXFL-529; LXFL 529; LXFL529; LXF 529 | 100000.0 | nM | GI50 | C2926 | |
TKC019571 | DMS-114 | DMS-114; DMS114; Darmouth Medical School 114 | 24378.0 | nM | GI50 | C4917 | Orphanet_70573 |
TKC019571 | NCI-H460 | NCI.H460; H460; H-460; NCIH460; NCI-HUT-460; NCI-460 | 1476.0 | nM | GI50 | C4450 | |
TKC019571 | CAKI-1 | CAL 1; Centre Antoine Lacassagne-1 | 23121.0 | nM | GI50 | C3224 | |
TKC019571 | UACC-62 | UACC 62; UACC.62; UACC62; University of Arizona Cell Culture-62 | 10046.0 | nM | GI50 | C3224 | |
TKC019571 | P388/ADR | 8166.0 | nM | GI50 | C21602 | ||
TKC019571 | SF-295 | SF-295; SF.295; SF 295 | 21528.0 | nM | GI50 | C3058 | Orphanet_360 |
TKC019571 | IGROV-1 | Igrov-1; IGROV 1; IGR-OV1; IGROV1; Igrov1; IGR.OV1; IGROV; OV1/P; OV1/p; OV1-P | 30409.0 | nM | GI50 | C7979 | Orphanet_454723 |
TKC019571 | 786-0 | 786-o; 786O; 786-0; 786.O; 786-O RCC; RCC 786-O; RCC_7860; RCC 7860; 7860; 786-0WT | 100000.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC019571 | RXF 631 | RXF-631L; RXF631L; RXF 631; RXF-631; RXF631 | 100000.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC019571 | UACC-257 | UACC 257; UACC.257; UACC257; University of Arizona Cell Culture-257 | 16866.0 | nM | GI50 | C3224 | |
TKC019571 | SNB-78 | SNB78; Surgical Neurology Branch-78 | 67608.0 | nM | GI50 | C3058 | Orphanet_360 |
TKC019571 | DLD-1 | DLD 1; DLD1; CoCL3 | 25942.0 | nM | GI50 | C4349 | |
TKC019571 | CCRF-CEM | CCRF/CEM; CCRFCEM; CCRF.CEM; CCRF CEM; CCRF; CEM; CEM-CCRF; CEM-CCRF (CAMR); CCRF/CEM/0; CEM/0; CEM-0; CCRF-CEM/S; GM03671; GM03671C | 39902.0 | nM | GI50 | C7953 | Orphanet_99861 |
TKC019571 | NCI-H226 | NCI.H226; NCI H226; H226; H-226; HUT-226; HUT 226; NCIH226 | 2606.0 | nM | GI50 | C45662 | Orphanet_50251 |
TKC019571 | HT-29 | HT 29; HT29 | 59429.0 | nM | GI50 | C4349 | |
TKC019571 | SK-MEL-28 | SK-Mel-28; SK.MEL.28; SK-MEL 28; SK MEL-28; SK MEL 28; SK Mel 28; SKMel-28; SKMEL-28; SK-MEL28; SK-Mel28; SK Mel28; SKMEL28; SKMel28; SKmel28; SKML-28; SK28; AU-Mel; P-36; P36 | 62373.0 | nM | GI50 | C3510 | |
TKC019571 | RXF 393 | RXF393L; RXF-393 L; RXF-393; RXF 393; RXF.393; RXF393; RXF 393NL | 13614.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC019571 | COLO 205 | Colo 205; CoLo 205; COLO-205; Colo-205; COLO.205; Colo205; COLO205; Co 205; Colorado 205 | 18578.0 | nM | GI50 | C4349 | |
TKC019571 | HOP-18 | HOP 18; Hop 18; HOP18; Hop18; Hopkins-18 | 36058.0 | nM | GI50 | C4450 | |
TKC019571 | SN12K1 | 21928.0 | nM | GI50 | C9385 | Orphanet_217071 | |
TKC019571 | HepG2 | 10.0 | % | Inhibition | C3728 | Orphanet_449 | |
TKC019571 | RAW264.7 | RAW264 | 17.0 | % | Activity | C21604 |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC019571 | P10636 | Microtubule-associated protein tau | MAPT | 4467 | nM | Potency |
TKC019571 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | TDP1 | 2661 | nM | Potency |
TKC019571 | P10275 | Androgen receptor | AR | 19953 | nM | Potency |
TKC019571 | P27695 | DNA-(apurinic or apyrimidinic site) endonuclease | APEX1 | 891 | nM | Potency |
TKC019571 | O75496 | Geminin | GMNN | 5805 | nM | Potency |
TKC019571 | P0DTD1 | Replicase polyprotein 1ab | rep | 24 | % | Inhibition |
TKC019571 | P28482 | Mitogen-activated protein kinase 1 | MAPK1 | 32 | nM | Potency |
TKC019571 | P83916 | Chromobox protein homolog 1 | CBX1 | 89125 | nM | Potency |
TKC019571 | P46063 | ATP-dependent DNA helicase Q1 | RECQL | 39811 | nM | Potency |
TKC019571 | P10520 | Streptokinase A | ska | >150000 | nM | EC50 |
TKC019571 | P02545 | Prelamin-A/C | LMNA | 35481 | nM | Potency |
TKC019571 | P16473 | Thyrotropin receptor | TSHR | 15849 | nM | Potency |
TKC019571 | P46098 | 5-hydroxytryptamine receptor 3A | HTR3A | 257040 | nM | IC50 |
TKC019571 | Q75NA5 | Gamma-aminobutyric acid receptor subunit beta | Rdl | 122 | % | Activity |
TKC019571 | Q7Z2W7 | Transient receptor potential cation channel subfamily M member 8 | TRPM8 | 100 | uM | Activity |
TKC019571 | Q9R0P9 | Ubiquitin carboxyl-terminal hydrolase isozyme L1 | Uchl1 | 18000 | nM | IC50 |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
P10636 | TAU_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P10636 | TAU_HUMAN | Alzheimer disease [ICD-11: 8A20] |
P10636 | TAU_HUMAN | Mild neurocognitive disorder [ICD-11: 6D71] |
P10636 | TAU_HUMAN | Choreiform disorder [ICD-11: 8A01] |
P10636 | TAU_HUMAN | Parkinsonism [ICD-11: 8A00] |
P10636 | TAU_HUMAN | Central nervous system disease [ICD-11: 8A04-8D87] |
P10636 | TAU_HUMAN | Neurodegenerative disorder [ICD-11: 8A20-8A23] |
P10275 | ANDR_HUMAN | Acne vulgaris [ICD-11: ED80] |
P10275 | ANDR_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P10275 | ANDR_HUMAN | Alcoholic liver disease [ICD-11: DB94] |
P10275 | ANDR_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
P10275 | ANDR_HUMAN | Cardiovascular disease [ICD-11: BA00-BE2Z] |
P10275 | ANDR_HUMAN | Chronic obstructive pulmonary disease [ICD-11: CA22] |
P10275 | ANDR_HUMAN | Female pelvic pain [ICD-11: GA34] |
P10275 | ANDR_HUMAN | Hypo-osmolality/hyponatraemia [ICD-11: 5C72] |
P10275 | ANDR_HUMAN | Low bone mass disorder [ICD-11: FB83] |
P10275 | ANDR_HUMAN | Mammary tumour [ICD-11: 2C60-2C6Z] |
P10275 | ANDR_HUMAN | Pituitary gland disorder [ICD-11: 5A60-5A61] |
P10275 | ANDR_HUMAN | Prostate cancer [ICD-11: 2C82] |
P10275 | ANDR_HUMAN | Testicular dysfunction [ICD-11: 5A81] |
P10275 | ANDR_HUMAN | Prostate hyperplasia [ICD-11: GA90] |
P10275 | ANDR_HUMAN | Alopecia [ICD-11: ED70] |
P10275 | ANDR_HUMAN | Chronic kidney disease [ICD-11: GB61] |
P10275 | ANDR_HUMAN | Thrombosis [ICD-11: DB61-GB90] |
P10275 | ANDR_HUMAN | Contraceptive management [ICD-11: QA21] |
P10275 | ANDR_HUMAN | Heart failure [ICD-11: BD10-BD1Z] |
P10275 | ANDR_HUMAN | Muscle disorder [ICD-11: FB32-FB3Z] |
P10275 | ANDR_HUMAN | Muscular dystrophy [ICD-11: 8C70] |
P10275 | ANDR_HUMAN | Cystic fibrosis [ICD-11: CA25] |
P10275 | ANDR_HUMAN | Pain [ICD-11: MG30-MG3Z] |
P10275 | ANDR_HUMAN | Cachexia [ICD-11: MG20] |
P10275 | ANDR_HUMAN | Dissociative neurological symptom disorder [ICD-11: 6B60] |
P10275 | ANDR_HUMAN | Bladder cancer [ICD-11: 2C94] |
P10275 | ANDR_HUMAN | Oesophagitis [ICD-11: DA24] |
P10275 | ANDR_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P10275 | ANDR_HUMAN | Prostate hyperplasia [ICD-11: GA90] |
P10275 | ANDR_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
P10275 | ANDR_HUMAN | Prostate cancer [ICD-11: 2C82] |
P10275 | ANDR_HUMAN | Acne vulgaris [ICD-11: ED80] |
P10275 | ANDR_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P27695 | APEX1_HUMAN | Retinopathy [ICD-11: 9B71] |
P27695 | APEX1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P27695 | APEX1_HUMAN | Ocular cancer [ICD-11: 2D00-2D07] |
P27695 | APEX1_HUMAN | Brain cancer [ICD-11: 2A00] |
P27695 | APEX1_HUMAN | Melanoma [ICD-11: 2C30] |
P28482 | MK01_HUMAN | Melanoma [ICD-11: 2C30] |
P28482 | MK01_HUMAN | Pancreatic cancer [ICD-11: 2C10] |
P28482 | MK01_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P28482 | MK01_HUMAN | Arteries/arterioles disorder [ICD-11: BD52] |
P28482 | MK01_HUMAN | Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
P28482 | MK01_HUMAN | Transplant rejection [ICD-11: NE84] |
P28482 | MK01_HUMAN | Mature T-cell lymphoma [ICD-11: 2A90] |
P28482 | MK01_HUMAN | Rheumatoid arthritis [ICD-11: FA20] |
P16473 | TSHR_HUMAN | Hypo-thyroidism [ICD-11: 5A00] |
P16473 | TSHR_HUMAN | Thyroid cancer [ICD-11: 2D10] |
P46098 | 5HT3A_HUMAN | Chronic pain [ICD-11: MG30] |
P46098 | 5HT3A_HUMAN | Corneal disease [ICD-11: 9A76-9A78] |
P46098 | 5HT3A_HUMAN | Epilepsy/seizure [ICD-11: 8A61-8A6Z] |
P46098 | 5HT3A_HUMAN | Irritable bowel syndrome [ICD-11: DD91] |
P46098 | 5HT3A_HUMAN | Nausea/vomiting [ICD-11: MD90] |
P46098 | 5HT3A_HUMAN | Gastro-oesophageal reflux disease [ICD-11: DA22] |
P46098 | 5HT3A_HUMAN | Schizophrenia [ICD-11: 6A20] |
Q7Z2W7 | TRPM8_HUMAN | Upper respiratory tract disorder [ICD-11: CA0Z] |
Q7Z2W7 | TRPM8_HUMAN | Pain [ICD-11: MG30-MG3Z] |
Q7Z2W7 | TRPM8_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q7Z2W7 | TRPM8_HUMAN | General pain disorder [ICD-11: 8E43] |